LONDON--(BUSINESS WIRE)--MultiOmic Health, an artificial intelligence (AI)-enabled drug discovery company, has closed a £5 million (US$6.2 million) seed funding extension round to build its precision ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Meharry Medical Ventures is ...
Existing investors Highland Europe, Mercuri and MMC Ventures will retain minority stakes The transaction is expected to close in Q4 2025 Battery’s Collier Searle and Dave Tabors will join Signal AI’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results